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Summary
 Background Colonoscopy screening and polypectomy are one of the most effective ways to 
reduce the incidence of colon cancer. One of the best achievements in Poland 
is the Colorectal Screening Programme that was started in 2000.
 Aim The aim of our study is to present the results of the examination made by the 
Endoscope Department of Great Poland Cancer Centre in the framework of the 
Polish Screening Programme for early diagnosis of colon cancer in the years 2004 
and 2005.
 Materials/Methods We admitted to the screening programme asymptomatic persons aged 50–65 
years (main group), persons between 40 and 65 years old with familial history of 
colorectal cancer, and people aged 25–65 from HNPCC or FAP families.
 Results We examined 1000 individuals. 982 total colonoscopies (98.2% effectiveness) 
were done, and ﬁ nally 806 polyps were removed. Adenomas were found in 83 
removed polyps (10%), including neoplastics lesions in 24 (28.9%) cases: tub-
ulovillous adenomas in 15 (18.1%), villous adenomas in 5 (6.0%) and serrated 
adenomas in 4 (4.8%) cases. Two of the removed polyps (0.2%) were malignant. 
Summarized colorectal neoplasia was detected in 26 (2.6%) participants. We ob-
served a 0.9% complication rate among all the participants.
 Conclusions The fundamental importance and consequence of early cancer detection and 
removal of premalignant adenomatous polyps has been shown to prevent death 
due to colorectal cancer and to reduce colorectal cancer incidence. Screening 
by colonoscopy with polypectomy can be an excellent and safe procedure with 
good levels of acceptability and high level yield for advanced colorectal neopla-
sia.
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BACKGROUND
Colorectal cancer is the second most common 
cancer and the second leading cause of death 
among men and women in Poland. Colorectal 
cancer incidence is high (30–35/100,000) and 
is rising by 2.5% per year. The ﬁ ve-year surviv-
al rate does not exceed 25%, which means that 
about 50% of colorectal patients are already di-
agnosed at advanced stage. Several methods of 
colorectal cancer screening appear to be effec-
tive in reducing disease-speciﬁ c mortality, but 
the cost-effectiveness of different strategies is 
unclear and still under study. Colorectal cancer 
is the third most common cancer in both men 
and women in the United States of America. 
However, the number of new cases of colorectal 
cancer and the number of deaths due to colorec-
tal cancer (in the USA) have decreased, which is 
attributed to increased screening and polyps re-
moval [1]. A number of arguments support the 
concept that colonic adenomatous polyps are 
premalignant. In epidemiological studies an as-
sociation between the occurrence of adenom-
as and colon cancer was found. Malignant foci 
have been observed in otherwise benign-appear-
ing adenomas. Histological and genetic markers 
absent in normal colon mucosa have been found 
in both benign and malignant neoplasms. Our 
outcome was the endoscopic detection of signif-
icant colorectal neoplasia, which included aden-
ocarcinoma, high-grade dysplasia, villous tissue, 
adenomas 1 cm or greater and multiple adeno-
mas of any size. Scientists are still studying color-
ectal cancer screening methods, both alone and 
in combination, to determine how effective they 
are. Studies are also under way to clarify the risks 
of each test. Arguments for colonoscopy as an 
elementary colorectal screening procedure are: 
the possibility of direct visualization of the whole 
colon and to allow biopsy for histopathological 
examination and/or removal of polyps, leading 
to reduction of mortality in colorectal cancer 
[2]. Actually, we know that colonoscopic screen-
ing and polypectomy are one of the most effec-
tive ways to reduce the incidence of colon can-
cer. One of the best achievements in Poland is 
the Colorectal Screening Programme that was 
started in 2000.
AIM
The aim of our study is to present the results 
of the examination made by our Endoscope 
Department in the framework of the Polish 
Screening Programme for early diagnosis of co-
lon cancer in the years 2004 and 2005.
MATERIALS AND METHODS
We admitted to the screening programme asymp-
tomatic persons between 50 and 65 years old 
(main group) and between 40 and 65 years with 
incidence of colorectal cancer in familial histo-
ry. Finally apart from the above groups we ex-
amined people aged 25–65 years from fami-
lies with syndromes predisposing to colorectal 
cancer: hereditary nonpolyposis colorectal can-
cer (HNPCC) or familial adenomatous polypo-
sis (FAP). The last group of patients was also 
consulted by the Genetics Unit. We invited for 
screening only by posters. Colonoscopy was cho-
sen as a proper tool for the programme, and as 
a rule we removed all found polyps which were 
up to 10 mm in diameter. The larger ones were 
not treated in the framework of the programme. 
Management after screening colonoscopy is pre-
sented in Table 1.
RESULTS
We examined 1000 (620 women and 380 men) 
people. We made 982 total colonoscopies (98.2% 
effectiveness), removing 806 polyps within the 
group of 179 people (removal from 1 to 34 pol-
yps per case). In 18 cases we were unable to assess 
the whole colon during the process. Therefore, 
for these patients we made a complementary ex-
amination, such as double contrast barium enema 
(DCBE). For polyps resection, wire loop and ar-
gon plasma coagulation (APC) after forced biop-
sy were used. All removed polyps were examined 
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by a histopathologist. We performed 109 APC, 44 
wire loops and 26 APC and loop together proce-
dures. 10 patients with polyps (of diameter 10–40 
mm) were not included in the programme. They 
were referred for hospital treatment. We per-
formed in 7 cases endoscopic polypectomies and 
in 3 cases open surgery resections. Histological 
examination revealed that two of the removed 
polyps (0.2%) were malignant. In both cases the 
polypectomy was sufﬁ cient treatment. The exci-
sion line was free of the invasive carcinoma and 
the margin of healthy tissue was large enough. 
In a number of removed polyps the domination 
of hyperplastic polyps was enormous. Adenomas 
were found in 83 removed polyps (10%), includ-
ing neoplastics lesions in 24 (28.9%) cases: tub-
ulovillous adenomas in 15 (18.1%), villous ade-
nomas in 5 (6.0%) and serrated adenomas in 4 
(4.8%) cases. The histological types of removed 
polyps and types of adenomas are presented in 
Tables 2 and 3. We observed in 9 (5%) cases such 
complications as bleeding (1 case), postpolypec-
tomy coagulation syndrome (1 case) and extend-
ed abdominal pain (7 cases). Second colonos-
copy with APC in the case with bleeding and 
conservative therapy in other cases were enough. 
Two patients were hospitalized for 1 (the patient 
with bleeding) and 5 days (the patient with post-
polypectomy coagulation syndrome). There were 
no serious complications. All complications are 
presented in Table 4.
DISCUSSION
Early diagnosis of colorectal cancer, like other 
kinds of cancers, is the basis of successful treat-
ment. Because of involvement of some polyps 
in colorectal cancergenesis many prevention 
Result Family history of colon cancer Recommendation
Norm Negative Colonoscopy after 10 years
Norm Positive Colonoscopy after 5 years
Adenoma size smaller than 10mm after 
screening polypectomy (1–2) Negative Colonoscopy after 10 years
Adenoma size smaller than 10mm after 
screening polypectomy (any number) Positive Colonoscopy after 5 years
Adenoma size greater than 1cm (even one), 
many more adenomas or contraindications 
against ambulatory care polypectomy 
No signifi cance Endoscopic treatment outside the programme
Large size fl at adenomas No signifi cance Endoscopic treatment outside programme
Colorectal cancer Positive fi rst-degree relative examinations Surgical treatment
Patients with hnpcc and fap According to defi nition
Dependent on results of colonoscopy and 
genetic counselling: colonoscopy after 2–3 
years or surgical treatment
Inadequate bowel preparation Colonoscopy again after one more bowel preparation –individual decision
Other cases Individual recommendation
Table 1. Management after colonoscopy in screening programme.
Adenomas  83 (10.0%)
Hyperplastic polyps  76 (9.4%)
Chronic infl ammatory (non-specifi c)  17 (2.0%)
Leiomyoma  1 (0.12%)
Malignant polyps  2 (0.2%)
Table 2. Histological types of removed polyps.
Adenomas
Tubular  59 (71.1%)
Tubulovillous  15 (18.1%)
Villous  5 (6.0%)
Serrated  4 (4.8%)
Table 3. Histological types of adenomas.
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programmes are focused on detecting and 
removing them. The term intestinal polyp is 
used to describe any projection arising from ﬂ at 
mucosa into the intestinal lumen. Polyps can 
be classiﬁ ed as neoplastic and nonneoplastic. 
Neoplastic polyps can be further classiﬁ ed as ei-
ther adenomatous (premalignant) or malignant. 
Approximately 95% of all colorectal carcinomas 
are believed to arise from adenomas, a ﬁ nding 
that underscores the importance of treatment 
and surveillance of adenomas of the gastrointes-
tinal tract. Adenomas represent approximately 
60% of all polyps removed during colonoscop-
ic examination of the colon. The cancer risk of 
adenomas is related to their macroscopic ap-
pearance (i.e. size, attachment, location) as well 
as their microscopic architecture and degree of 
dysplasia. These descriptors are used clinically to 
predict the malignant potential of a polyp and to 
guide both treatment and future surveillance in-
tervals. In our examinations we have looked for 
colorectal neoplasia, which included adenocar-
cinoma, high-grade dysplasia, villous tissue, ade-
nomas 1 cm or greater and multiple adenomas. 
Colorectal cancer is believed to progress through 
an adenoma-carcinoma sequence. However, re-
cent evidence increasingly supports the existence 
of an alternative route for colorectal carcinogen-
esis through serrated polyps, a group that en-
compasses a morphological spectrum, including 
hyperplastic polyp, admixed hyperplastic polyp/
adenoma, and serrated adenoma; the latter two 
manifest epithelial dysplasia. In our examination 
we performed polypectomy in 179 (18.2%) par-
ticipants. Adenomas were found in 83 removed 
polyps (10%), including neoplastics lesions in 
24 (28.9%) cases: tubulovillous adenomas in 15 
(18.1%), villous adenomas in 5 (6.0%) and ser-
rated adenomas in 4 (4.8%) cases. Two of the re-
moved polyps (0.2%) were malignant. In summa-
ry, we detected colorectal neoplasia in 26 (2.6%) 
participants. Our results form only a small part 
of the Polish Screening Programme for early di-
agnosis of colon cancer. In autumn 2000 screen-
ing colonoscopy was introduced into the National 
Cancer Prevention Programme in Poland. So far, 
50,148 participants’ colonoscopies have been per-
formed. Advanced neoplasia was detected in 2553 
(5.9%) participants from 50 to 66 years old and in 
243 (3.4%) participants between 40 and 49 years 
old. The rate of complications during colonoscopy 
was 0.1%, and no participants died. We observed 
a 0.9% rate of complications among all partici-
pants. Most of the situations regarded as compli-
cations after polypectomy should be named “inci-
dental events” rather than “complications”, as they 
can often be successfully treated in the polypec-
tomy process. The most frequent complication, 
abdominal pain, is a result of ﬂ atulence made by 
argon, a noble gas dispersing into the large and 
small bowel very quickly during APC. According 
to the literature data screening by colonoscopy 
is invasive and may cause haemorrhage in 1:500 
patients and colonic perforation in 1:2000 [3] 
but in our opinion colonoscopy and colonoscop-
ic polypectomy are safe techniques.
It was found that advanced neoplasia occurs at a 
signiﬁ cantly higher rate in men than in women, 
which may warrant reﬁ nement of the screening 
recommendations for colorectal cancer [4]. In 
October 2002 screening coloscopy was introduced 
into the National Cancer Prevention Programme 
in Germany. A total of 109,989 colonoscopies 
(43% in males) were evaluated from October 
2003 to July 2005. In most of the polyps immedi-
ate polypectomy was carried out. The complication 
rate was low (0.1%) and no deaths were observed. 
Neoplasias of the colon were detected in about 
20% of persons who had taken part in a colonos-
copy screening programme. The high rate of early 
stages of colorectal cancers detected by screening 
colonoscopy is an indirect indicator of mortality 
reduction. In Germany screening colonoscopy 
Complication Partof colon
Method
of removal
Number of cases
– 179 
Hospital
stay Treatment
Bleeding Caecum Loop 1 (0.6%) 1 day Second colonoscopy apc
Postpolypectomy 
coagulation 
syndrome 
Sigmoid Loop 1 (0.6%) 5 days Conservative
Abdominal pain
(1–2 H.) All APC (a lot of polyps) 7 (3.9%) 0
Toilet –decompression 
necessary
Table 4. Complications.
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has a low risk [5]. Colonoscopy screening is still 
controversial. A lot of authors have tried to prove 
the worth of sigmoidoscopy as a useful tool of 
screening [6]. We know that ﬂ exible sigmoidos-
copy screening of the average risk population 
has been recommended as one of the screening 
options to reduce both incidence and mortality 
[7,8]. Clinical ﬁ ndings for screening ﬂ exible sig-
moidoscopy have already been reported for the 
European trials [9–11]. In the PLCO (Prostate, 
Lung, Colorectal and Ovarian (PLCO) cancer 
screening trial) trial, 80% of colorectal cancers 
associated with positive sigmoidoscopy were dis-
covered in the distal colon, as one might expect 
from a procedure that examines the distal colon 
primarily. However, the induction of colonosco-
py by screening enables evaluation and treatment 
of the proximal colon. Detection of any adenoma 
is a positive factor qualifying for full colonosco-
py and the ﬁ nal results of cost-effectiveness assess-
ment are more unfavourable for sigmoidoscopy 
than colonoscopy screening. Lieberman and Weiss 
studied 2885 asymptomatic subjects aged 50–75 
years who provided stool specimens and under-
went a complete colonoscopy [2]. Examination of 
the ﬁ rst 60 cm of the rectum and sigmoid colon 
during colonoscopy was used as a surrogate for 
sigmoidoscopy, and “any adenoma” was deﬁ ned 
as a positive screening test. They concluded that 
only sigmoidoscopy would miss about 30% of pa-
tients with advanced proximal neoplasms.
Colorectal cancer is a common disease with a 
long lead-time and easily recognized precursor 
lesions, making screening a rational and effec-
tive means of prevention. Colonoscopy from age 
50 is accepted as an accurate and cost-effective 
screening modality of colorectal cancer screen-
ing with high speciﬁ city and low false-positive rate 
but is not yet the ‘preferred’ strategy [2,12,13]. In 
these conditions despite the risk, inconvenience 
and cost, colonoscopy is a valid primary screen-
ing tool for colorectal cancer. A large number of 
patients with adenomas are now being uncovered 
as a result of the increased use of colorectal can-
cer screening, particularly the dramatic increase 
in screening colonoscopy, which places a huge 
burden on medical resources applied to surveil-
lance [14–16]. In populations where colonoscopy 
screening was done the number of deaths due to 
colorectal cancer has decreased, which is attrib-
uted to increased examination participation and 
polyp removal [1]. Therefore, there is a need for 
increased efﬁ ciency of surveillance colonoscopy 
practices to reduce the cost and risk and increase 
the availability of prophylactic colonoscopy.
CONCLUSIONS
Finally based on our own experience and litera-
ture data we conclude that: (i) fundamental im-
portance and consequence of early cancer detec-
tion and removal of premalignant adenomatous 
polyps has been shown to prevent death due to 
colorectal cancer and to reduce colorectal can-
cer incidence; (ii) screening by colonoscopy with 
polypectomy can be an excellent and safe proce-
dure with good levels of acceptability, and high 
level yield for advanced colorectal neoplasia.
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